Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Highfill

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Translational Medicine|May 10, 2020
Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell productsAlex Lu, Hui Liu, Rongye Shi, et al.
Cytotherapy|March 19, 2023
Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assaysJinxia Ma, Lipei Shao, Tatyana Fuksenko, et al.
Cytotherapy|December 12, 2023
Assessment and comparison of viability assays for cellular productsYihua Cai, Michaela Prochazkova, Yong-Soo Kim, et al.
Cancer Immunology Research|August 24, 2016
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for SarcomasAdrienne H Long, Steven L Highfill, Yongzhi Cui, et al.
Blood|September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaQing Zhou, Christoph Bucher, Meghan E Munger, et al.
Journal of Translational Medicine|July 18, 2018
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron<sup>®</sup> (Peginterferon alfa-2b) and Actimmune<sup>®</sup> (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancerDaniel S Green, Ana T Nunes, Virginia David-Ocampo, et al.
Oncogene|April 6, 2004
Deregulated expression of LRBA facilitates cancer cell growthJia-Wang Wang, Joshua J Gamsby, Steven L Highfill, et al.
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Blood|September 3, 2010
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13Steven L Highfill, Paulo C Rodriguez, Qing Zhou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyBrynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Translational Medicine|May 10, 2020
Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell productsAlex Lu, Hui Liu, Rongye Shi, et al.
Cytotherapy|March 19, 2023
Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assaysJinxia Ma, Lipei Shao, Tatyana Fuksenko, et al.
Cytotherapy|December 12, 2023
Assessment and comparison of viability assays for cellular productsYihua Cai, Michaela Prochazkova, Yong-Soo Kim, et al.
Cancer Immunology Research|August 24, 2016
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for SarcomasAdrienne H Long, Steven L Highfill, Yongzhi Cui, et al.
Blood|September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaQing Zhou, Christoph Bucher, Meghan E Munger, et al.
Journal of Translational Medicine|July 18, 2018
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron<sup>®</sup> (Peginterferon alfa-2b) and Actimmune<sup>®</sup> (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancerDaniel S Green, Ana T Nunes, Virginia David-Ocampo, et al.
Oncogene|April 6, 2004
Deregulated expression of LRBA facilitates cancer cell growthJia-Wang Wang, Joshua J Gamsby, Steven L Highfill, et al.
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Blood|September 3, 2010
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13Steven L Highfill, Paulo C Rodriguez, Qing Zhou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyBrynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Pageof 6